(Q39327530)

11 September 2017

title

COPD exacerbation frequency, pharmacotherapy and resource use: an observational study in UK primary care (English)

1 reference

chronic obstructive pulmonary disease

11 September 2017

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24152210%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

Amr Radwan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24152210%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Carol Stonham

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24152210%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Sam Marshall

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24152210%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

language of work or name

English

0 references

publication date

23 October 2013

1 reference

COPD: Journal of Chronic Obstructive Pulmonary Disease

11 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24152210%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24152210%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24152210%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

300-309

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24152210%20AND%20SRC:MED&resulttype=core&format=json

The burden of COPD in the U.K.: results from the Confronting COPD survey.

3 June 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.841671

Accuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care audit

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.841671

The clinical features of the overlap between COPD and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.841671

Longitudinal changes in the nature, severity and frequency of COPD exacerbations.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.841671

Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.841671

Costs of chronic bronchitis and COPD: a 1-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.841671

The burden of COPD in the U.S.A.: results from the Confronting COPD survey

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.841671

Direct costs of COPD in the U.S.: an analysis of Medical Expenditure Panel Survey (MEPS) data

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.841671

The costs of exacerbations in chronic obstructive pulmonary disease (COPD).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.841671

Factors affecting chronic obstructive pulmonary disease (COPD)-related costs: a multivariate analysis of a Swedish COPD cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.841671

Costs of COPD in Sweden according to disease severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.841671

Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.841671

Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.841671

Impact of COPD exacerbations on patient-centered outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.841671

Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.841671

Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.841671

Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.841671

Inappropriate overuse of inhaled corticosteroids for COPD patients: impact on health costs and health status.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.841671

Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.841671

Withdrawal of inhaled corticosteroids in individuals with COPD--a systematic review and comment on trial methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.841671

Knowledge of guidelines for the management of COPD: a survey of primary care physicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.841671

Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2013.841671